Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia

NCT06046352 | Completed

• 1 other identifier: 19/562
• Study Type: observational
• Target: 711
• Locations: 1 country
• Sites: 1

Brief Summary

BELIEVE-SVT is a European multi-centre, retrospective registry in tertiary hospitals performing electrophysiological study in patients with palpitations considered clinically suggestive of paroxysmal supraventricular tachycardia by a cardiologist and without electrocardiographic documentation of tachycardia or preexcitation. Clinical characteristics, results of electrophysiological study and ablation, complications, and clinical outcomes during follow-up will be analysed.

Conditions

Supraventricular Tachycardia

Outcome Measures

Primary Outcomes (1)

• Electrophysiological study findings

  Number of participants in whom paroxysmal supraventricular tachycardia or evidence of substrate enabling paroxysmal supraventricular tachycardia is observed in electrophysiological study

  5 years

Study Arms (1)

Cohort

Non-documented, clinically-suspected PSVT

Procedure: Electrophysiological study (and ablation when appropriate)

Interventions

Electrophysiological study (and ablation when appropriate) PROCEDURE

Electrophysiological study (and ablation when appropriate)

Cohort

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with palpitations clinically suggestive of paroxysmal supraventricular tachycardia but no ECG documentation of tachycardia

You may qualify if:

• Symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist
• Absence of any sort of ECG tracing during episodes (including wearables and other single lead devices)

You may not qualify if:

• Documentation of preexcitation
• Prior electrophysiological study aimed at the assessment of ventriculo-atrial conduction or induction of supraventricular tachycardias.

Sponsors & Collaborators

• Hospital Universitario 12 de Octubre: lead

Study Sites (1)

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

Location

MeSH Terms

Conditions

Tachycardia, Supraventricular

Condition Hierarchy (Ancestors)

Tachycardia; Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Cardiac Conduction System Disease; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Daniel Rodriguez, MD PhD

  University Hospital 12 de Octubre

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 12, 2023
• First Posted: September 21, 2023
• Study Start: December 17, 2019
• Primary Completion: November 2, 2021
• Study Completion: June 1, 2022
• Last Updated: September 21, 2023

Record last verified: 2023-09

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)